¼¼°èÀÇ ¹ÙÀÌ¿ÀÀǾàǰ ºÎÇüÁ¦ ½ÃÀå ±Ô¸ð Á¶»ç : Á¦Ç°, ±â´É, ¿ëµµ ¹× Áö¿ªº° ¿¹Ãø(2024-2032³â)
Global Biopharmaceutical Excipients Market Size Study by Product, Function, Application and Regional Forecasts 2024-2032
»óǰÄÚµå : 1517427
¸®¼­Ä¡»ç : Bizwit Research & Consulting LLP
¹ßÇàÀÏ : 2024³â 07¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 200 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 4,950 £Ü 7,162,000
Unprintable PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠺Ұ¡´ÉÇϸç, ÅØ½ºÆ®ÀÇ Copy&Pasteµµ ºÒ°¡´ÉÇÕ´Ï´Ù.
US $ 6,250 £Ü 9,043,000
Printable PDF (Enterprise License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

¼¼°èÀÇ ¹ÙÀÌ¿ÀÀǾàǰ ºÎÇüÁ¦ ½ÃÀåÀº 2023³â ¾à 22¾ï 9,000¸¸ ´Þ·¯·Î Æò°¡µÇ¾ú°í, 2024-2032³âÀÇ ¿¹Ãø ±â°£ µ¿¾È 10.75% ÀÌ»óÀÇ °ß½ÇÇÑ ¼ºÀå·ü·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¹ÙÀÌ¿ÀÀǾàǰ ºÎÇüÁ¦´Â ÀǾàǰÀÇ »ý»ê¼º, ¾ÈÁ¤¼º, »ç¿ë¼º ¹× Àü´ÞÀ» Çâ»ó½Ã۱â À§ÇØ ¹ÙÀÌ¿ÀÀǾàǰ Á¦Á¦¿¡ Æ÷ÇԵǴ Áß¿äÇÑ ºñȰ¼º ¹°ÁúÀÔ´Ï´Ù. ºÎÇüÁ¦´Â °áÇÕÁ¦, ÃæÀüÁ¦, Èñ¼®Á¦, ºØ±«Á¦, ¾ÈÁ¤Á¦ µî ´Ù¾çÇÑ ¿ªÇÒÀ» ¼öÇàÇϸç ÀǾàǰ Á¦Á¦È­ °úÁ¤¿¡¼­ ÇʼöÀûÀÎ ¿ªÇÒÀ» ÇÕ´Ï´Ù. ½ÃÀå ¼ºÀåÀÇ ÁÖ¿ä ¿øµ¿·ÂÀº ÷´Ü ±â´É¼º ÀǾàǰ Á¦Á¦¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡¿Í ´ëÇü ºÐÀÚ °³¹ß¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡ÀÔ´Ï´Ù. ÀǾàǰ °³¹ß¿¡ ´ëÇÑ ÅõÀÚ°¡ ±ÞÁõÇϸ鼭 ¹ÙÀÌ¿ÀÀǾàǰ ºÎÇüÁ¦ÀÇ »ç¿ëÀÌ ´õ¿í Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ±×·¯³ª ¹ÙÀÌ¿ÀÀǾàǰ°ú ¿ø·áÀǾàǰÀÇ ÀûÇÕ¼º ¹®Á¦°¡ Å« À̽´·Î ¶°¿À¸£°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ¹ÙÀÌ¿ÀÀǾàǰ°ú ¹ÙÀÌ¿À½Ã¹Ð·¯ÀÇ Áö¼ÓÀûÀÎ °³¹ßÀº ÀûÇÕÇÑ ºÎÇüÁ¦ÀÇ ÅëÇÕÀ» ÇÊ¿ä·Î ÇÕ´Ï´Ù. ¼­¹æÇü Á¦Á¦ÀÇ ±â¼ú ¹ßÀü°ú ´ëü Åõ¿© °æ·ÎÀÇ Å½»öÀº ½ÃÀå È®´ëÀÇ Å« ÀáÀç·ÂÀ» º¸¿©ÁÖ°í ÀÖ½À´Ï´Ù.

¶ÇÇÑ, ź¼öÈ­¹°Àº Á¦Á¦ÀÇ ¾ÈÁ¤¼º°ú ȯÀÚÀÇ ¼øÀÀµµ¸¦ ³ôÀÌ´Â ¿ªÇÒÀ» Çϱ⠶§¹®¿¡ ÀǾàǰ Á¦Á¦¿¡ »ç¿ëµÇ´Â Áß¿äÇÑ ºÎÇüÁ¦ÀÔ´Ï´Ù. µ¦½ºÆ®·Î½º, ÀüºÐ, ÀÚ´ç µî ´Ù¾çÇÑ Åº¼öÈ­¹°Àº Áõ·®Á¦, ÃæÁøÁ¦, ¾ÈÁ¤Á¦ µî Áß¿äÇÑ ±â´ÉÀ» Á¦°øÇÏ¿© ¹ÙÀÌ¿À ÀǾàǰÀÇ ÀúÀå ±â°£°ú È¿´ÉÀ» Çâ»ó½Ãŵ´Ï´Ù. ¸¸´ÏÅç, ¼Ò¸£ºñÅç°ú °°Àº Æú¸®¿Ãµµ ¼öºÐÀ» Á¶ÀýÇϰí À¯È¿ ¼ººÐÀÇ ¿ëÇØµµ¸¦ Çâ»ó½ÃÄÑ ¹ÙÀÌ¿À ÀǾàǰ Á¦Á¦¿¡¼­ Áß¿äÇÑ ¿ªÇÒÀ» ÇÕ´Ï´Ù.

¾ÈÁ¤¼ºÀ» Çâ»ó½Ã۱â À§ÇØ »ý¹°ÇÐÀû Á¦Á¦¿¡¼­ ¹æºÎÁ¦ÀÇ »ç¿ëÀÌ Áõ°¡Çϰí ÀÖ´Â °ÍÀº ÁÖ¸ñÇÒ ¸¸ÇÕ´Ï´Ù. °áÇÕÁ¦, ÄÚÆÃÁ¦, ºØ±«Á¦, À±È°Á¦, À±È°Á¦, À±È°Á¦ ¹× ÃæÀüÁ¦´Â ÀǾàǰÀÇ ±¸Á¶Àû ¹«°á¼º, ¹æÃâ ¸ÞÄ¿´ÏÁò ¹× Åõ¿© Á¤È®µµ¸¦ º¸ÀåÇÏ´Â µ¥ ÇʼöÀûÀÔ´Ï´Ù. ÷´Ü Àü´Þ ½Ã½ºÅÛµµ Áß¿äÇÑ ÀÀ¿ë ºÐ¾ßÀ̸ç, ºÎÇüÁ¦´Â »ý¹°ÇÐÀû Ȱ¼º ºÐÀÚÀÇ Á¶ÀýµÈ ¹æÃâ, Ç¥ÀûÈ­ ¹× Èí¼ö¸¦ ÃËÁøÇÕ´Ï´Ù.

¼¼°èÀÇ ¹ÙÀÌ¿ÀÀǾàǰ ºÎÇüÁ¦ ½ÃÀå Á¶»ç¿¡¼­ °í·ÁµÈ ÁÖ¿ä Áö¿ªÀº ¾Æ½Ã¾ÆÅÂÆò¾ç, ºÏ¹Ì, À¯·´, ¶óƾ¾Æ¸Þ¸®Ä« ¹× ±âŸ ¼¼°è Áö¿ªÀÔ´Ï´Ù. ºÏ¹Ì´Â ¹ÙÀÌ¿ÀÀǾàǰ ºÎÇüÁ¦ ½ÃÀå¿¡¼­ °¡Àå Å« ¼öÀÍÀ» âÃâÇÏ´Â Áö¿ªÀÔ´Ï´Ù. ÀÌ Áö¿ª ½ÃÀå ¼ºÀåÀº źźÇÑ Á¦¾à »ê¾÷, ¿¬±¸°³¹ß¿¡ ´ëÇÑ ¸·´ëÇÑ ÅõÀÚ, ¾ÈÁ¤ÀûÀÎ FDA ½ÂÀÎ °Ç¼ö µîÀÇ ¿äÀο¡ ±âÀÎÇÕ´Ï´Ù. ÇÑÆí, ¾Æ½Ã¾ÆÅÂÆò¾ç ½ÃÀåÀº ÇコÄɾ ´ëÇÑ ³ë·Â, º´¿ø ³×Æ®¿öÅ©ÀÇ È®Àå, Á¦¾à ¹× ¹ÙÀÌ¿À ÀÇÇÐ ¿¬±¸ Áß½ÉÁö·Î¼­ÀÇ ¸í¼º Áõ°¡·Î ÀÎÇÑ ºü¸¥ ¼ºÀå¿¡ ÈûÀÔ¾î ¿¹Ãø ±â°£ µ¿¾È °¡Àå ºü¸¥ ¼Óµµ·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¸ñÂ÷

Á¦1Àå ¼¼°èÀÇ ¹ÙÀÌ¿ÀÀǾàǰ ºÎÇüÁ¦ ½ÃÀå ÁÖ¿ä ¿ä¾à

Á¦2Àå ¼¼°èÀÇ ¹ÙÀÌ¿ÀÀǾàǰ ºÎÇüÁ¦ ½ÃÀå Á¤ÀÇ¿Í Á¶»çÀÇ ÀüÁ¦Á¶°Ç

Á¦3Àå ¼¼°èÀÇ ¹ÙÀÌ¿ÀÀǾàǰ ºÎÇüÁ¦ ½ÃÀå ¿ªÇÐ

Á¦4Àå ¼¼°èÀÇ ¹ÙÀÌ¿ÀÀǾàǰ ºÎÇüÁ¦½ÃÀå »ê¾÷ ºÐ¼®

Á¦5Àå ¼¼°èÀÇ ¹ÙÀÌ¿ÀÀǾàǰ ºÎÇüÁ¦ ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø : Á¦Ç°º°, 2022³â-2032³â

Á¦6Àå ¼¼°èÀÇ ¹ÙÀÌ¿ÀÀǾàǰ ºÎÇüÁ¦ ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø : ±â´Éº°, 2022³â-2032³â

Á¦7Àå ¼¼°èÀÇ ¹ÙÀÌ¿ÀÀǾàǰ ºÎÇüÁ¦ ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø : ¿ëµµº°, 2022³â-2032³â

Á¦8Àå ¼¼°èÀÇ ¹ÙÀÌ¿ÀÀǾàǰ ºÎÇüÁ¦ ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø : Áö¿ªº°, 2022³â-2032³â

Á¦9Àå °æÀï Á¤º¸

Á¦10Àå Á¶»ç °úÁ¤

LSH
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Global Biopharmaceutical Excipients Market is valued at approximately USD 2.29 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 10.75% over the forecast period 2024-2032. Biopharmaceutical excipients are vital non-active substances incorporated into biopharmaceutical formulations to enhance production, stability, usability, and delivery of drugs. They serve various roles such as binders, fillers, diluents, disintegrants, and stabilizers, which are indispensable in drug formulation processes. The market growth is primarily driven by the increasing demand for advanced and functional drug formulations and the rising need for large-molecule development. Investments in drug development are soaring, further boosting the utilization of biopharmaceutical excipients. However, the compatibility issues of biopharmaceutical formulations with active pharmaceutical ingredients pose significant challenges. Additionally, the continuous development of biologics and biosimilars necessitates the integration of compatible excipients. Technological advancements in extended-release formulations and the exploration of alternative routes of administration present significant market expansion potential.

Moreover, carbohydrates are prominent excipients used in pharmaceutical formulations due to their roles in enhancing formulation stability and patient compliance. Various carbohydrates, such as dextrose, starch, and sucrose, offer critical functionalities including bulking agents, fillers, and stabilizers, thereby improving the shelf life and efficacy of biopharmaceuticals. Polyols like mannitol and sorbitol also play essential roles in biopharmaceutical formulations by controlling moisture and improving solubility of active ingredients.

The increasing utilization of preservatives in biologic formulations for improved stability is notable. Binders, coatings, disintegrants, lubricants, glidants, and fillers are essential for ensuring the structural integrity, release mechanisms, and dosage accuracy of pharmaceuticals. Advanced delivery systems are another significant application area, where excipients facilitate the controlled release, targeting, and absorption of biologically active molecules.

The key regions considered for the global Biopharmaceutical Excipients Market study include Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America is a dominating region in the Biopharmaceutical Excipients Market in terms of revenue. The market growth in the region is being attributed to factors including robust pharmaceutical industry, significant investment in R&D, and a steady number of FDA approvals. Whereas, the market in Asia Pacific is anticipated to grow at the fastest rate over the forecast period fueled by rapid growth driven by healthcare initiatives, expanding hospital networks, and the region's growing reputation as a pharmaceutical and biomedical research hub.

Major market players included in this report are:

The detailed segments and sub-segments of the market are explained below:

By Product:

By Function:

By Application:

By Region:

Years considered for the study are as follows:

Key Takeaways:

Table of Contents

Chapter 1. Global Biopharmaceutical Excipients Market Executive Summary

Chapter 2. Global Biopharmaceutical Excipients Market Definition and Research Assumptions

Chapter 3. Global Biopharmaceutical Excipients Market Dynamics

Chapter 4. Global Biopharmaceutical Excipients Market Industry Analysis

Chapter 5. Global Biopharmaceutical Excipients Market Size & Forecasts by Product 2022-2032

Chapter 6. Global Biopharmaceutical Excipients Market Size & Forecasts by Function 2022-2032

Chapter 7. Global Biopharmaceutical Excipients Market Size & Forecasts by Application 2022-2032

Chapter 8. Global Biopharmaceutical Excipients Market Size & Forecasts by Region 2022-2032

Chapter 9. Competitive Intelligence

Chapter 10. Research Process

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â